IPA logo

ImmunoPrecise Antibodies (IPA) Operating Expenses

Annual Operating Expenses

$19.12 M
-$8.84 M-31.62%

April 30, 2024


Summary


Performance

IPA Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIPAexpensesmetrics:

Quarterly Operating Expenses

$4.58 M
-$516.30 K-10.13%

October 31, 2024


Summary


Performance

IPA Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIPAexpensesmetrics:

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

IPA Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-31.6%-10.1%
3 y3 years+59.2%-10.1%
5 y5 years+118.7%-10.1%

IPA Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-31.6%+59.2%-52.0%+8.1%
5 y5-year-31.6%+118.7%-52.0%+150.4%
alltimeall time-31.6%>+9999.0%-52.0%+5196.6%

ImmunoPrecise Antibodies Operating Expenses History

DateAnnualQuarterly
Oct 2024
-
$4.58 M(-10.1%)
Jul 2024
-
$5.10 M(+4.5%)
Apr 2024
$19.12 M(-31.6%)
$4.88 M(+0.8%)
Jan 2024
-
$4.84 M(+14.2%)
Oct 2023
-
$4.24 M(-13.7%)
Jul 2023
-
$4.91 M(-1.8%)
Apr 2023
$27.95 M(+26.8%)
$5.00 M(-10.3%)
Jan 2023
-
$5.58 M(-29.9%)
Oct 2022
-
$7.96 M(-16.6%)
Jul 2022
-
$9.53 M(+59.4%)
Apr 2022
$22.04 M(+83.6%)
$5.98 M(+10.6%)
Jan 2022
-
$5.41 M(-6.1%)
Oct 2021
-
$5.76 M(+20.3%)
Jul 2021
-
$4.79 M(+14.9%)
Apr 2021
$12.01 M(+35.2%)
$4.17 M(+18.7%)
Jan 2021
-
$3.51 M(+34.6%)
Oct 2020
-
$2.61 M(+42.5%)
Jul 2020
-
$1.83 M(-19.2%)
Apr 2020
$8.88 M(+1.6%)
$2.26 M(+23.1%)
Jan 2020
-
$1.84 M(-30.0%)
Oct 2019
-
$2.63 M(+22.7%)
Jul 2019
-
$2.14 M(-28.5%)
Apr 2019
$8.74 M(+54.7%)
$3.00 M(+66.2%)
Jan 2019
-
$1.80 M(-7.4%)
Oct 2018
-
$1.95 M(+5.7%)
Jul 2018
-
$1.84 M(-11.0%)
Apr 2018
$5.65 M(+171.3%)
$2.07 M(+26.6%)
Jan 2018
-
$1.64 M(+40.1%)
Oct 2017
-
$1.17 M(+71.1%)
Jul 2017
-
$682.00 K(-42.8%)
Apr 2017
$2.08 M(>+9900.0%)
$1.19 M(+123.9%)
Jan 2017
-
$532.80 K(+4974.3%)
Sep 2016
-
$10.50 K(+45.8%)
Jun 2016
-
$7200.00(+132.3%)
Mar 2016
-
$3100.00(-72.3%)
Dec 2015
$5400.00(-83.8%)
-
Dec 2015
-
$11.20 K(+409.1%)
Sep 2015
-
$2200.00(-132.8%)
Jun 2015
-
-$6700.00(+204.5%)
Mar 2015
-
-$2200.00(-81.0%)
Dec 2014
$33.40 K(-61.6%)
-
Dec 2014
-
-$11.60 K(-143.1%)
Sep 2014
-
$26.90 K(+1482.4%)
Jun 2014
-
$1700.00(-90.1%)
Mar 2014
-
$17.10 K(-52.5%)
Dec 2013
$87.00 K(+7.1%)
-
Dec 2013
-
$36.00 K(+73.9%)
Sep 2013
-
$20.70 K(+69.7%)
Jun 2013
-
$12.20 K(-30.7%)
Mar 2013
-
$17.60 K(-49.4%)
Dec 2012
$81.20 K(-61.4%)
-
Dec 2012
-
$34.80 K(+89.1%)
Sep 2012
-
$18.40 K(+187.5%)
Jun 2012
-
$6400.00(-70.6%)
Mar 2012
-
$21.80 K(-51.3%)
Dec 2011
$210.10 K(-17.1%)
-
Dec 2011
-
$44.80 K(-30.7%)
Sep 2011
-
$64.60 K(+2.7%)
Jun 2011
-
$62.90 K(>+9900.0%)
Mar 2011
-
$500.00(-99.5%)
Dec 2010
$253.50 K
-
Dec 2010
-
$97.00 K(+99.2%)
Sep 2010
-
$48.70 K(+6857.1%)
Jun 2010
-
$700.00(-98.8%)
DateAnnualQuarterly
Mar 2010
-
$59.90 K(-38.8%)
Dec 2009
$236.50 K(-36.2%)
-
Dec 2009
-
$97.80 K(+98.0%)
Sep 2009
-
$49.40 K(+25.1%)
Jun 2009
-
$39.50 K(-24.5%)
Mar 2009
-
$52.30 K(-68.2%)
Dec 2008
$370.70 K(-35.6%)
-
Dec 2008
-
$164.50 K(+183.1%)
Sep 2008
-
$58.10 K(-17.7%)
Jun 2008
-
$70.60 K(+14.2%)
Mar 2008
-
$61.80 K(-86.6%)
Dec 2007
$575.80 K(+175.2%)
-
Dec 2007
-
$460.40 K(+946.4%)
Sep 2007
-
$44.00 K(-21.6%)
Jun 2007
-
$56.10 K(+15.0%)
Mar 2007
-
$48.80 K(-154.3%)
Dec 2006
$209.20 K(+23.3%)
-
Dec 2006
-
-$89.90 K(-358.3%)
Sep 2006
-
$34.80 K(-83.9%)
Jun 2006
-
$215.90 K(+325.8%)
Mar 2006
-
$50.70 K(+13.2%)
Dec 2005
$169.70 K(+10.1%)
-
Dec 2005
-
$44.80 K(+78.5%)
Sep 2005
-
$25.10 K(-36.8%)
Jun 2005
-
$39.70 K(-76.3%)
Mar 2005
-
$167.70 K(+419.2%)
Dec 2004
$154.10 K(-30.2%)
-
Jun 2004
-
$32.30 K(-25.1%)
Mar 2004
-
$43.10 K(-70.5%)
Dec 2003
$220.80 K(+119.7%)
-
Dec 2003
-
$146.30 K(+600.0%)
Sep 2003
-
$20.90 K(-39.8%)
Jun 2003
-
$34.70 K(+35.0%)
Mar 2003
-
$25.70 K(+21.8%)
Dec 2002
$100.50 K(-19.9%)
-
Dec 2002
-
$21.10 K(+2.4%)
Sep 2002
-
$20.60 K(-39.6%)
Jun 2002
-
$34.10 K(+37.5%)
Mar 2002
-
$24.80 K(-4233.3%)
Dec 2001
$125.50 K(+25.1%)
-
Dec 2001
-
-$600.00(-101.1%)
Sep 2001
-
$54.00 K(-25.6%)
Jun 2001
-
$72.60 K(+181.4%)
Mar 2001
-
$25.80 K(-6.5%)
Dec 2000
$100.30 K(-19.0%)
-
Dec 2000
-
$27.60 K(+23.2%)
Sep 2000
-
$22.40 K(-13.2%)
Jun 2000
-
$25.80 K(+6.2%)
Mar 2000
-
$24.30 K(-5.8%)
Dec 1999
$123.80 K(-20.9%)
-
Dec 1999
-
$25.80 K(-0.8%)
Sep 1999
-
$26.00 K(-28.6%)
Jun 1999
-
$36.40 K(+2.8%)
Mar 1999
-
$35.40 K(-23.9%)
Dec 1998
$156.50 K(-22.3%)
-
Dec 1998
-
$46.50 K(+45.3%)
Sep 1998
-
$32.00 K(-25.9%)
Jun 1998
-
$43.20 K(+25.6%)
Mar 1998
-
$34.40 K(-32.7%)
Dec 1997
$201.50 K(+20.4%)
-
Dec 1997
-
$51.10 K(+38.1%)
Sep 1997
-
$37.00 K(-53.5%)
Jun 1997
-
$79.50 K(+138.0%)
Mar 1997
-
$33.40 K
Dec 1996
$167.30 K
-

FAQ

  • What is ImmunoPrecise Antibodies annual total operating expenses?
  • What is the all time high annual operating expenses for ImmunoPrecise Antibodies?
  • What is ImmunoPrecise Antibodies annual operating expenses year-on-year change?
  • What is ImmunoPrecise Antibodies quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for ImmunoPrecise Antibodies?
  • What is ImmunoPrecise Antibodies quarterly operating expenses year-on-year change?

What is ImmunoPrecise Antibodies annual total operating expenses?

The current annual operating expenses of IPA is $19.12 M

What is the all time high annual operating expenses for ImmunoPrecise Antibodies?

ImmunoPrecise Antibodies all-time high annual total operating expenses is $27.95 M

What is ImmunoPrecise Antibodies annual operating expenses year-on-year change?

Over the past year, IPA annual total operating expenses has changed by -$8.84 M (-31.62%)

What is ImmunoPrecise Antibodies quarterly total operating expenses?

The current quarterly operating expenses of IPA is $4.58 M

What is the all time high quarterly operating expenses for ImmunoPrecise Antibodies?

ImmunoPrecise Antibodies all-time high quarterly total operating expenses is $9.53 M

What is ImmunoPrecise Antibodies quarterly operating expenses year-on-year change?

Over the past year, IPA quarterly total operating expenses has changed by -$516.30 K (-10.13%)